BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 313510)

  • 1. Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma.
    Bloomfield CD; Gajl-Peczalska KJ; Frizzera G; Kersey JH; Goldman AI
    N Engl J Med; 1979 Sep; 301(10):512-8. PubMed ID: 313510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of lymphocytic surface markers and histology in adult non-Hodgkin's lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Cancer Treat Rep; 1977 Sep; 61(6):963-70. PubMed ID: 332359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.
    Lukes RJ; Taylor CR; Parker JW; Lincoln TL; Pattengale PK; Tindle BH
    Am J Pathol; 1978 Feb; 90(2):461-86. PubMed ID: 304674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A new functional interpretation of malignant lymphomas. The Lukes-Collins classification and its basis].
    Maurer R; Lukes RJ
    Schweiz Med Wochenschr; 1979 Jan; 109(3):76-86. PubMed ID: 310578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Lukes-Collins and Kiel classifications for non-Hodgkin lymphomas. A retrospective study considering both classifications and their relationships to stage, sex, age, and survival.
    Blanco G; Alavaikko M; Apaja-Sarkkinen M; Taskinen PJ
    Anticancer Res; 1986; 6(2):267-79. PubMed ID: 3707063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface marker identification of small cleaved follicular center cell lymphomas with a highly favorable prognosis.
    Rudders RA; Ahl ET; Delellis RA; Bernstein S; Begg CB
    Cancer Res; 1982 Jan; 42(1):349-53. PubMed ID: 7053861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lukes-Collins classification and its significance.
    Lukes RJ; Collins RD
    Cancer Treat Rep; 1977 Sep; 61(6):971-9. PubMed ID: 302740
    [No Abstract]   [Full Text] [Related]  

  • 8. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of lymphocyte surface markers in adult non-Hodgkin's malignant lymphoma.
    Bloomfield CD; Kersey JH; Brunning RD; Gajl-Peczalska KJ
    Lancet; 1976 Dec; 2(7999):1330-3. PubMed ID: 63805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent views on the functional histological classification of malignant lymphomas].
    Guarino M; Caldara G
    Arch Sci Med (Torino); 1975; 132(1):1-8. PubMed ID: 1080409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
    Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difference in prognosis between T- and B-cell lymphomas: clinical study at Shikoku Cancer Center Hospital.
    Toki H; Okabe K; Kimura Y; Yumoto Y; Morita M; Ogushi I; Koike S; Takashima S; Sato G; Moriwaki S
    Jpn J Clin Oncol; 1986 Mar; 16(1):41-8. PubMed ID: 3486301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome and prognostic factors in ocular adnexal lymphoma.
    Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
    Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The Lukes-Collins classification and the Kiel classification of non-Hodgkin's lymphomas].
    Blanco G; Alavaikho M; Apaja-Sarkkinen M; Taskinen PJ
    Vopr Onkol; 1987; 33(1):46-50. PubMed ID: 3811309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant lymphomas: cell surface markers and advances in classification.
    Strauchen JA
    West J Med; 1981 Oct; 135(4):276-84. PubMed ID: 6979127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the Lukes and Collins classification in patient treated with COMLA.
    Sweet DL; Collins RD; Stein RS; Ultmann JE
    Cancer Treat Rep; 1982 May; 66(5):1107-11. PubMed ID: 7044531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Hodgkin's lymphomas. Analysis of 92 cases using the 'international' classification.
    Bain GO
    Arch Pathol Lab Med; 1983 Feb; 107(2):64-9. PubMed ID: 6600607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow and blood involvement by lymphoma in relationship to the Lukes--Collins classification.
    Foucar K; McKenna RW; Frizzera G; Brunning RD
    Cancer; 1982 Mar; 49(5):888-97. PubMed ID: 6977408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic and cytochemical cell markers in non-Hodgkin's lymphomas.
    Davey FR; Goldberg J; Stockman J; Gottlieb AJ
    Lab Invest; 1976 Nov; 35(5):430-8. PubMed ID: 792563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A clinical perspective on cell markers in acute lymphocytic leukemia.
    Bowman WP; Melvin SL; Aur RJ; Mauer AM
    Cancer Res; 1981 Nov; 41(11 Pt 2):4794-801. PubMed ID: 6975162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.